
Phathom Pharmaceuticals PHAT
$ 11.7
-3.78%
Annual report 2025
added 02-26-2026
Phathom Pharmaceuticals Total Inventories 2011-2026 | PHAT
Annual Total Inventories Phathom Pharmaceuticals
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5.52 M | 3.21 M | 1.21 M | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 5.52 M | 1.21 M | 3.31 M |
Quarterly Total Inventories Phathom Pharmaceuticals
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.43 M | 3.17 M | 3.21 M | 3.11 M | 2.18 M | - | 1.21 M | 111 K | 111 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 3.43 M | 111 K | 2.07 M |
Total Inventories of other stocks in the Biotechnology industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Aptorum Group Limited
APM
|
39.1 K | $ 0.9 | -2.33 % | $ 6.62 M | ||
|
ACADIA Pharmaceuticals
ACAD
|
91.7 M | $ 21.96 | -0.68 % | $ 3.64 B | ||
|
Amphastar Pharmaceuticals
AMPH
|
177 M | $ 21.41 | 1.9 % | $ 1 B | ||
|
Aquestive Therapeutics
AQST
|
6.17 M | $ 4.08 | 0.25 % | $ 436 M | ||
|
Arcutis Biotherapeutics
ARQT
|
22.6 M | $ 23.26 | 1.75 % | $ 2.96 B | ||
|
Autolus Therapeutics plc
AUTL
|
33.2 M | $ 1.44 | -5.88 % | $ 383 M | ||
|
BioDelivery Sciences International
BDSI
|
23.7 M | - | -4.8 % | $ 255 M | ||
|
BeiGene, Ltd.
BGNE
|
608 M | - | 0.49 % | $ 251 B | ||
|
bluebird bio
BLUE
|
22.9 M | - | - | $ 546 M | ||
|
BioXcel Therapeutics
BTAI
|
722 K | $ 1.06 | -3.64 % | $ 12.9 M | ||
|
Cara Therapeutics
CARA
|
2.82 M | - | -3.03 % | $ 260 M |